<DOC>
	<DOCNO>NCT00216892</DOCNO>
	<brief_summary>Patients psoriasis vulgaris trunk and/or limb randomise treatment : 1 . 4 week ointment contain calcipotriol betamethasone dipropionate follow 8 week calcipotriol cream 2 . 4 week ( calcipotriol plus betamethasone dipropionate ) ointment follow 8 week calcipotriol cream weekdays/ ( calcipotriol plus betamethasone dipropionate ) ointment weekend 3 . 4 week ( calcipotriol plus betamethasone dipropionate ) ointment follow 8 week vehicle calcipotriol cream The objective compare efficacy safety different treatment regimen</brief_summary>
	<brief_title>Efficacy Safety Calcipotriol Cream ( Calcipotriol + Betamethasone Dipropionate ) Ointment Psoriasis Vulgaris</brief_title>
	<detailed_description>A phase IV study different treatment regimen calcipotriol 50 mcg/g cream combination ( calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g ( dipropionate ) ) ointment follow treatment combination ointment psoriasis vulgaris</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Patients psoriasis vulgaris trunk and/or limb</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>